Epizyme

Creates drugs to treat patients with genetic predispositions to cancer. The company is currently working on treatments for genetically-linked leukemia, Non-Hodgkin’s lymphoma and breast cancer. Cofounder Horvitz won the Nobel Prize for Medicine in 2002. The company raised $4 million in venture funding from GlaxoSmithKline in October 2011.